At a time when shedding pounds may be just a shot away, WeightWatchers is returning to its roots and its community to chart a ...

In today’s CEO Daily: Diane Brady talks to GoodRx CEO Wendy Barnes. The big story: Trump, Putin, and Zelensky headed for ...

Columnist Teri Sforza writes that studies have found that semaglutide reduced alcohol intake, binge drinking and relapse ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to "align with federal coverage requirements." ...

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

“From 2019 to 2024, the percentage of adult patients with a diagnosis of overweight or obesity increased 50.7 percent, and ...

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

Recent federal and state developments have shifted the ground under medispas. The US Food and Drug Administration (FDA) ...

Discover how Danone's Oikos Fusion yogurt drink caters to weight management and muscle retention, particularly for those ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...